Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRNP | P04156 | 1/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.61 |
| ▸ | MEN1 | O00255 | 7/20 | 0.61 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.57 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.57 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | AHR | P35869 | 1/20 | 0.47 |
| ▸ | CDC25B | P30305 | 1/20 | 0.46 |
| ▸ | FABP4 | P15090 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | ATIC | P31939 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6913251 | 0.98 | PRNP (0.73) | PRNPKMT2AMEN1NR4A1NR4A2 | |
| SCHEMBL6915323 | 0.98 | PRNP (0.73) | PRNPKMT2AMEN1NR4A1NR4A2 | |
| SCHEMBL6915637 | 0.98 | PRNP (0.73) | PRNPKMT2AMEN1NR4A1NR4A2 | |
| SCHEMBL6913620 | 0.98 | PRNP (0.73) | PRNPKMT2AMEN1NR4A1NR4A2 | |
| SCHEMBL6913244 | 0.98 | PRNP (0.73) | PRNPKMT2AMEN1NR4A1NR4A2 | |
| SCHEMBL6913860 | 0.98 | PRNP (0.73) | PRNPKMT2AMEN1NR4A1NR4A2 | |
| SCHEMBL6913857 | 0.98 | PRNP (0.73) | PRNPKMT2AMEN1NR4A1NR4A2 | |
| SCHEMBL6916189 | 0.98 | PRNP (0.73) | PRNPKMT2AMEN1NR4A1NR4A2 | |
| SCHEMBL6913618 | 0.98 | PRNP (0.73) | PRNPKMT2AMEN1NR4A1NR4A2 | |
| Hydrochloric Acid SCHEMBL11734513 | 0.98 | PRNP (0.73) | PRNPKMT2AMEN1NR4A1NR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112945912-B | High-brightness large-Stokes-shift wash-free lipid-droplet fluorescent probe and synthetic method and application thereof | 中国科学院大连化学物理研究所 | 2023-02-21 | — | — | CN | claimed |
| CN-112945912-A | High-brightness large-Stokes-shift wash-free lipid-droplet fluorescent probe and synthetic method and application thereof | 中国科学院大连化学物理研究所 | 2021-06-11 | — | — | CN | claimed |
| CN-109134371-B | Fluorescence ratio probe, synthetic method thereof and application of fluorescence ratio probe in detecting intracellular lysosome formaldehyde | 东北大学 | 2020-07-10 | — | — | CN | claimed |
| EP-4652154-A1 | NOVEL ALPK1 INHIBITORS | Pyrotech (Beijing) Biotechnology Co., Ltd. (CN) | 2025-11-26 | — | — | EP | disclosed |
| US-20250345446-A1 | BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES | DRAUPNIR BIO APS (DK) | 2025-11-13 | — | — | US | disclosed |
| US-20250289812-A1 | COMPOUND FOR TREATING THROMBOTIC DISEASES | RUIJIN HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE (CN) | 2025-09-18 | — | — | US | disclosed |
| US-12378224-B2 | Heteroaryl compounds and their use as Mer inhibitors | DONG-A SOCIO HOLDINGS CO., LTD. (KR) | 2025-08-05 | — | — | US | disclosed |
| EP-4565121-A1 | CARBON MONOXIDE PROBE MOLECULES | Georgia State University Research Foundation, Inc. (US) | 2025-06-11 | — | — | EP | disclosed |
| CN-119997870-A | Carbon monoxide probe molecule | 乔治亚州立大学研究基金会股份有限公司 | 2025-05-13 | — | — | CN | disclosed |
| EP-4543858-A1 | BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES | Draupnir Bio ApS (DK) | 2025-04-30 | — | — | EP | disclosed |
| WO-2024153225-A1 | NOVEL ALPK1 INHIBITORS | PYROTECH (BEIJING) BIOTECHNOLOGY CO., LTD. (CN) | 2024-07-25 | — | — | WO | disclosed |
| US-4946987-A | Treatment for complications of diabetes | AYERST, MCKENNA & HARRISON, INC. (CA) | 1990-08-07 | — | — | US | disclosed |
| US-4705882-A | ALDOSE REDUCTASE INHIBITORS, ANTIDIABETIC AGENTS | AYERST, MCKENNA & HARRISON, INC. (CA) | 1987-11-10 | — | — | US | disclosed |
| US-4600724-A | ALDOSE REDUCTASE INHIBITOR, DIABETES | AYERST, MCKENNA & HARRISON, INC. (CA) | 1986-07-15 | — | — | US | disclosed |
| US-4568693-A | ANTIDIATBETIC AGENTS | AYERST, MCKENNA & HARRISON, INC. (CA) | 1986-02-04 | — | — | US | disclosed |
| EP-0059596-B1 | N-NAPHTHOYLGLYCINE DERIVATIVES | AYERST, MCKENNA AND HARRISON INC. (CA) | 1985-04-24 | — | — | EP | disclosed |
| US-4439617-A | TREATING DIABETES, ENZYME INHIBITOR | AYERST, MCKENNA & HARRISON INC. (CA) | 1984-03-27 | — | — | US | disclosed |
| US-4391816-A | ANTIDIABETIC AGENTS | AYERST, MCKENNA & HARRISON INC. (CA) | 1983-07-05 | — | — | US | disclosed |
| EP-0059596-A1 | N-Naphthoylglycine derivatives | AYERST, MCKENNA AND HARRISON INC. (CA) | 1982-09-08 | — | — | EP | disclosed |
| US-3980667-A | Anti-arrhythmic 5-endo-substituted oxy-N-(aminoloweralkyl)bicycle [2.2.2.]oc | BRISTOL-MYERS COMPANY (US) | 1976-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289812-A1 | COMPOUND FOR TREATING THROMBOTIC DISEASES | ITGB3, SRC, FYN | PRNP 1761/4885KMT2A 4193/4885MEN1 3939/4885 |
| US-12378224-B2 | Heteroaryl compounds and their use as Mer inhibitors | MERTK, RET, ERBB2 | PRNP 424/4885KMT2A 2442/4885MEN1 379/4885 |
| US-20250345446-A1 | BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES | SORT1, SCARB1, LAMP1 | PRNP 2740/4885KMT2A 4557/4885MEN1 2813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.